Next Article in Journal
A Data-Driven Approach to Construct a Molecular Map of Trypanosoma cruzi to Identify Drugs and Vaccine Targets
Next Article in Special Issue
Results on SARS-CoV-2 mRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis
Previous Article in Journal
Risk Analysis Stratification of CIN 2+ Development in a Cohort of Women Living with HIV with Negative Pap Smear and HR-HPV Test during a Long-Term Follow-Up
Previous Article in Special Issue
Safety, Efficacy, and Immunogenicity of Varying Types of COVID-19 Vaccines in Children Younger Than 18 Years: An Update of Systematic Review and Meta-Analysis
 
 
Article

Article Versions Notes

Vaccines 2023, 11(2), 266; https://doi.org/10.3390/vaccines11020266
Action Date Notes Link
article pdf uploaded. 26 January 2023 11:14 CET Version of Record https://www.mdpi.com/2076-393X/11/2/266/pdf-vor
article xml file uploaded 14 February 2023 06:35 CET Original file -
article xml uploaded. 14 February 2023 06:35 CET Update -
article pdf uploaded. 14 February 2023 06:35 CET Updated version of record https://www.mdpi.com/2076-393X/11/2/266/pdf-vor
article html file updated 14 February 2023 06:37 CET Original file -
article xml file uploaded 21 February 2023 09:48 CET Update -
article xml uploaded. 21 February 2023 09:48 CET Update https://www.mdpi.com/2076-393X/11/2/266/xml
article pdf uploaded. 21 February 2023 09:48 CET Updated version of record https://www.mdpi.com/2076-393X/11/2/266/pdf
article html file updated 21 February 2023 09:50 CET Update -
article html file updated 8 March 2023 02:26 CET Update https://www.mdpi.com/2076-393X/11/2/266/html
Back to TopTop